Results 21 to 30 of about 446,360 (313)

Immunohistochemical study of VEGF-A, VEGFR-1, VEGFR-2 and CD34 expression in сolorectal adenocarcinoma progression

Patologìâ, 2019
Aim – to study VEGF-A, VEGFR-1, VEGFR-2 and CD34 immunohistochemical expression on the I, II, III, IV stages (pTNM) of colorectal adenocarcinoma development. Materials and methods.
M. A. Shyshkin
doaj   +1 more source

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2023
Kun He,* Xinyu Liu,* Zelong Yang Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zelong Yang, Department
He K, Liu X, Yang Z
doaj  

Vascular Endothelial Growth Factor A in Eyes With Uveal Melanoma [PDF]

Archives of Ophthalmology, 2006
To determine the presence of vascular endothelial growth factor A (VEGF-A) in the aqueous humor of eyes with uveal melanoma and to identify its source.The VEGF-A concentrations were determined in aqueous humor samples obtained after enucleation from 74 eyes with untreated uveal melanoma and from 8 eyes with treated uveal melanoma.
Missotten, G.S., Notting, I.C., Schlingemann, R.O., Zijlmans, H.J., Lau, C., Eilers, P.H., Keunen, J.E.E., Jager, M.J.   +7 more
openaire   +4 more sources

Immunohistochemical Expression of Vascular Endothelial Growth Factor and Its Correlation With Tumor Grade in Breast Ductal Carcinoma [PDF]

Acta Medica Iranica, 2011
Breast cancer is the most common cause of cancer-related death in female, after lung cancer. Angiogenesis is essential for tumor growth and metastasis; therefore, antiangiogenesis strategies for treatment of cancer are currently an issue of interest. The
Laleh Vahedi Larijani, Roghaieh Moghimpour, Saeid Abediankenari, Ahmadreza Bekhradnia, Farshad Naghshvar, Omid Emadian, Maryam Ghasemi   +6 more
doaj   +2 more sources

Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals

Egyptian Liver Journal, 2021
Background Hepatocellular carcinoma (HCC) comprises 5.6% of all cancers worldwide representing the sixth most common cancer. It is also the fourth most common cause of cancer-related mortality.
Ahmed Mohamed ElGhandour, Essam Mohamed Bayoumy, Wesam Ahmed Ibrahim, Moataz Mohamed Sayed, Ashraf Bekheet Salama, Nahla Mohamed Teama, Mohamed Magdy Salama   +6 more
doaj   +1 more source

Serum vascular endothelial growth factor: a prognostic factor in cervical cancer [PDF]

Journal of Cancer Research and Clinical Oncology, 2008
To study pre-treatment serum VEGF of patients with invasive cervical cancer and its possible role as prognostic indicator.VEGF was measured using ELISA in the largest patient group (n = 167) to date.Serum VEGF was significantly higher in advanced tumor stage (P = 0.01), large tumor size (tumors larger than 2 cm) (P = 0.03), and the presence of vascular
Zusterzeel, P.L.M., Span, P.N., Dijksterhuis, M.G., Thomas, C.M.G., Sweep, C.G.J., Massuger, L.F.A.G.   +5 more
openaire   +3 more sources

Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background We recently discovered a small endogenous peptide, peptide Lv, with the ability to activate vascular endothelial growth factor receptor 2 and its downstream signaling.
Liheng Shi, Min Zhao, Colette A. Abbey, Shu‐Huai Tsai, Wankun Xie, Dylan Pham, Samantha Chapman, Kayla J. Bayless, Travis W. Hein, Robert H. Rosa, Michael L. Ko, Lih Kuo, Gladys Y.‐P. Ko   +12 more
doaj   +1 more source

Targeting Vascular endothelial growth factor A with soluble vascular endothelial growth factor receptor 1 ameliorates nerve injury-induced neuropathic pain

Molecular Pain, 2022
Neuropathic pain is a distressing medical condition with few effective treatments. The role of Vascular endothelial growth factor A (VEGFA) in inflammation pain has been confirmed in many researches. However, the mechanism of VEGFA affects neuropathic pain remains unclear.
Zhe Peng, Fan Yang, Siting Huang, Yang Tang, Li Wan   +4 more
openaire   +2 more sources

Hematopoietic (stem) cells—The elixir of life?

FEBS Letters, EarlyView.
The aging of HSCs (hematopoietic stem cells) and the blood system leads to the decline of other organs. Rejuvenating aged HSCs improves the function of the blood system, slowing the aging of the heart, kidney, brain, and liver, and the occurrence of age‐related diseases.
Emilie L. Cerezo, Jonah Anderson, Emilie Dinh Vedrenne, Noël Yeh Martín, Jette Lengefeld   +4 more
wiley   +1 more source

Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer [PDF]

International Journal of Clinical Oncology, 2019
There are few studies on serum vascular endothelial growth factors and receptors (VEGF/VEGFRs) in patients with uterine cervical cancer (CC). The aim of this study was to determine whether VEGF/VEGFRs could be used as prognostic biomarkers in patients with CC.A total of 107 patients with stage IB to IIB CC, who underwent radical hysterectomy at Tottori
Mayumi Sawada, Tetsuro Oishi, Hiroaki Komatsu, Shinya Sato, Jun Chikumi, Michiko Nonaka, Akiko Kudoh, Daiken Osaku, Tasuku Harada   +8 more
openaire   +2 more sources